Literature DB >> 16414009

Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.

Zhiping Li1, Yoshio Hosoi, Keshong Cai, Yuji Tanno, Yoshihisa Matsumoto, Atsushi Enomoto, Akinori Morita, Keiichi Nakagawa, Kiyoshi Miyagawa.   

Abstract

Exposure of MDA-MB-468 cells to ionizing radiation (IR) caused biphasic activation of ERK as indicated by its phosphorylation at Thr202/Tyr204. Specific epidermal growth factor receptor (EGFR) inhibitor AG1478 and specific Src inhibitor PP2 inhibited IR-induced ERK1/2 activation but phosphatidylinositol-3 kinase inhibitor wortmannin did not. IR caused EGFR tyrosine phosphorylation, whereas it did not induce EGFR autophosphorylation at Tyr992, Tyr1045, and Tyr1068 or Src-dependent EGFR phosphorylation at Tyr845. SHP-2, which positively regulates EGFR/Ras/ERK signaling cascade, became activated by IR as indicated by its phosphorylation at Tyr542. This activation was inhibited by PP2 not by AG1478, which suggests Src-dependent activation of SHP-2. Src and PTPalpha, which positively regulates Src, became activated as indicated by phosphorylation at Tyr416 and Tyr789, respectively. These data suggest that IR-induced ERK1/2 activation involves EGFR through a Src-dependent pathway that is distinct from EGFR ligand activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414009     DOI: 10.1016/j.bbrc.2005.12.193

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.

Authors:  Lu Kong; Zhihong Deng; Haiying Shen; Yuxiang Zhang
Journal:  Mol Cell Biochem       Date:  2010-11-04       Impact factor: 3.396

2.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

3.  GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.

Authors:  Holly A Jensen; Rodica P Bunaciu; Jeffrey D Varner; Andrew Yen
Journal:  Cell Signal       Date:  2015-03-26       Impact factor: 4.850

4.  FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.

Authors:  Kathryn Graham; Kim Moran-Jones; Owen J Sansom; Valerie G Brunton; Margaret C Frame
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors.

Authors:  Goutam Chakraborty; Nabeela Khan Patail; Rahim Hirani; Subhiksha Nandakumar; Ying Z Mazzu; Yuki Yoshikawa; Mohammad Atiq; Lina E Jehane; Konrad H Stopsack; Gwo-Shu Mary Lee; Wassim Abida; Michael J Morris; Lorelei A Mucci; Daniel Danila; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2020-12-17       Impact factor: 13.801

6.  Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia.

Authors:  Xiaohan Hu; Xiangyang Wu; Jiali Xu; Jin Zhou; Xiao Han; Jun Guo
Journal:  BMC Neurosci       Date:  2009-07-14       Impact factor: 3.288

7.  The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells.

Authors:  Holly A Jensen; Lauren E Styskal; Ryan Tasseff; Rodica P Bunaciu; Johanna Congleton; Jeffrey D Varner; Andrew Yen
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

8.  Involvement of connexin43 hemichannel in ATP release after γ-irradiation.

Authors:  Yasuhiro Ohshima; Mitsutoshi Tsukimoto; Hitoshi Harada; Shuji Kojima
Journal:  J Radiat Res       Date:  2012-06-12       Impact factor: 2.724

Review 9.  Cellular functions regulated by phosphorylation of EGFR on Tyr845.

Authors:  Ken-Ichi Sato
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

10.  GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.

Authors:  Zhiqiang Mo; Manran Liu; Fangfang Yang; Haojun Luo; Zhenhua Li; Gang Tu; Guanglun Yang
Journal:  Breast Cancer Res       Date:  2013-11-29       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.